Examkin

Soru

Zorluk: OrtaPediatric Endocrine Disorders

A 7-year-old girl is brought to the pediatrician by her father, who recently noticed that she is developing breasts and has experienced a rapid increase in height over the past year. Vital signs are within normal limits for her age. Physical examination reveals Tanner stage 3 breast development and Tanner stage 2 pubic hair. No axillary hair or acne is noted, and the neurological examination is unremarkable. The physician suspects an early onset of puberty. Arrange the following steps in the most appropriate chronological sequence for the diagnostic evaluation and management of this patient's condition.

  1. 1Obtain a radiograph of the left wrist and hand
  2. 2Measure basal serum luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels
  3. 3Perform a gonadotropin-releasing hormone (GnRH) stimulation test
  4. 4Obtain a magnetic resonance imaging (MRI) scan of the brain
  5. 5Initiate treatment with a long-acting GnRH agonist

Cevap

The correct sequence is: radiograph of the left wrist, measure basal LH/FSH, perform a GnRH stimulation test, obtain a brain MRI, and finally initiate treatment with a long-acting GnRH agonist.
The standard approach to evaluating and managing precocious puberty requires a stepwise logical progression. First, true precocious puberty is established using a bone age radiograph. Second, the source is biochemically localized to the central nervous system by checking basal LH and FSH. Third, if basal levels are equivocal, a GnRH stimulation test definitively proves pituitary sensitization. Fourth, structural CNS abnormalities are excluded via an MRI of the brain. Finally, once idiopathic central precocious puberty is established and tumors are ruled out, continuous GnRH agonist therapy is initiated to desensitize the pituitary.

Adım Adım Çözüm

1
Assess skeletal maturation via bone age radiograph.
Differentiates true precocious puberty (advanced bone age) from benign premature thelarche (normal bone age).
It is the most cost-effective and least invasive initial test to determine if the physical changes represent a systemic progression of puberty.
2
Evaluate the hypothalamic-pituitary-gonadal (HPG) axis via basal gonadotropins.
High basal LH indicates central precocious puberty; low LH requires further stimulation testing.
Determines whether the puberty is gonadotropin-dependent (central) or independent (peripheral).
3
Perform a GnRH stimulation test if basal levels are inconclusive.
A robust rise in LH confirms central precocious puberty.
Basal LH can sometimes be prepubertal even in early central precocious puberty; dynamic testing reveals the sensitized pituitary.
4
Exclude intracranial pathology with a brain MRI.
Rules out tumors, hamartomas, or structural anomalies.
Central precocious puberty in young children (especially girls under 8 years old) carries a risk of underlying CNS lesions.
5
Start pharmacotherapy with a long-acting GnRH agonist (e.g., leuprolide).
Suppresses the HPG axis, halts secondary sexual characteristic progression, and prevents premature epiphyseal fusion.
This is the definitive treatment for idiopathic central precocious puberty once life-threatening causes are excluded.

Anahtar Kavram

The diagnostic algorithm for precocious puberty begins with a bone age assessment, followed by hormonal localization (LH/FSH/GnRH stimulation), structural evaluation (MRI for central causes), and finally targeted pharmacotherapy.
Bu soruyu puanla

Konular

Pediatric Endocrine Disorders

Bu konudan daha fazla soru